Evidence mapPaperPMID 41909047Full record

SynthesisFrontiers in nutrition2026

Chen Shen, Xiao-Ti Wu, Xue-Feng Wang, Zhi-Jie Wang, Zi-Yu Tian, Nicola Robinson, Jian-Ping Liu

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chen Shen *Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xiao-Ti Wu *Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xue-Feng WangCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Zhi-Jie WangThe Oncology Department, Shanxi Hospital of Traditional Chinese Medicine, Taiyuan, China.
Zi-Yu TianInstitute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China.
Nicola RobinsonCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Jian-Ping LiuCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate effectiveness and safety of Methods: PubMed, the Cochrane Library, EMBASE, Web of Science, Scopus and four Chinese databases were searched up to January 9, 2025. Randomized and non-randomized clinical studies, cohort studies, or case-control studies were included for cancer patients using Results: Ten studies (seven randomized trials, two non-randomized studies, one cohort study) with 8,898 participants were included. Compared to chemotherapy alone, Conclusion: Systematic review registration: The review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO, CRD42025646003).

Indexed as

adjuvant therapyAsparagaceaebioactive compoundscancer careintegrative oncologyquality of lifesurvivalvegetable

Identifiers

PMID41909047
PMCPMC13017270

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.